Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Hims & Hers will stop selling compound GLP-1 drugs under a lawsuit settlement, ending their telehealth availability.

flag Hims & Hers Health will discontinue selling compound GLP-1 medications as part of a settlement in a lawsuit, according to a court filing. flag The company did not admit wrongdoing but agreed to the terms to resolve allegations related to the marketing and distribution of the drugs. flag The move affects its telehealth offerings and comes amid increased scrutiny of weight-loss and diabetes treatments sold online.

23 Articles